Breaks Categories: News

ThursdayMay 20, 2021 9:56 am

NetworkNewsBreaks – Presidio Property Trust (NASDAQ: SQFT) Reports Q1 2021 Results, Company Status

Presidio Property Trust (NASDAQ: SQFT), an internally managed REIT that has a diversified portfolio of commercial and industrial properties and model homes, has released its first quarter 2021 financial and business report. Included in the report is the note that Presidio achieved an average rental collection rate of 96% during the first-quarter period, a figure that the company attributes to the diversified nature of its property portfolio. The company also reported that revenue for the quarter was $5.7 million, a 19% decrease of approximately $1.3 million from Q1 2020, which reflects the sale of four properties. Based on what the…

Continue Reading

WednesdayMay 19, 2021 2:20 pm

NetworkNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Closes Acquisition of Oregon-Based Retail Store Chain

Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF), operating as Chalice Brands, a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale and distribution, today announced the signing of a definitive agreement today, May 19, and concurrent closing of the purchase of 100% ownership in SMS Ventures, LLC, dba Homegrown Oregon, a chain of five retail dispensaries located in Portland, Salem and Albany, Oregon. “Management is excited to combine with Homegrown and fully expects to continue its migration to better valuations for shareholders as we continue to execute our acquisition strategy. As part of our West Coast-focused growth strategy, we…

Continue Reading

WednesdayMay 19, 2021 2:09 pm

NetworkNewsBreaks – TFF Pharmaceuticals Inc. (NASDAQ: TFFP) Closes $40M Follow-On Offering

TFF Pharmaceuticals (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (“TFF”) technology platform, announced that it has closed on its recent underwritten offering. The offering comprised 2,855,000 shares of TFFP common stock sold at the offering price of $14 per share. The announcement noted that 2,140,000 shares were sold by TFF Pharmaceuticals and 715,000 shares were sold by Lung Therapeutics Inc., a privately held company. The public offering resulted in approximately $40 million gross proceeds for TFF Pharmaceuticals. The company noted that it anticipated using its portion…

Continue Reading

WednesdayMay 19, 2021 1:42 pm

NetworkNewsBreaks – Knightscope Inc. Announces New Ways to Keep in Touch, Launch of Knightscope Store

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has released its last update on the StartEngine platform as, on advice of legal counsel, the company will no longer be posting nor replying to questions on the platform but has made other arrangements to stay in touch.  “Knightscope Investors Page - we are in the process of updating www.Knightscope.com/Investors where we will continue to post updates and, also soon, we will add a forum to the bottom of the page where you can post (appropriate) public comments and questions - and we will continue to…

Continue Reading

WednesdayMay 19, 2021 11:41 am

NetworkNewsBreaks – Tinkermen Lotto Report Launches Live Database Repository and Forum for Major World Lotteries

Tinkermen Lotto Report, a unique online lotto strategy company, today released information about its newly launched, game-changing lotto probability database repository and forum, which is designed to benefit lottery players around the world. The repository was built to change perceptions and show that lotteries, although made up of independent random draws, are also “mathematically deterministic” and “simply not quite as random as is publicly perceived,” explains company creator and industry expert Edvin Hiltner, author of Lottery Codex: Lottery Strategies According to Mathematics & the Fun of Responsible Gaming. In the past, with lottery jackpots built to unprecedented amounts, many participants…

Continue Reading

WednesdayMay 19, 2021 11:11 am

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Announces New Facility to House Indoor Plant Operations

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has a new warehouse located in Squamish, British Columbia. The new warehouse is a critical pieces of the company's expansion plans and will play a key supply chain role in the company’s distribution of indoor plants in Canada. With the global indoor plant market forecast to see a 10.24% growth rate and reach $7.2 million by 2026, PlantX is committed to its indoor plant vertical. The facility is a 3,000-square-foot, fully operational warehouse and will be co-managed by PlantX and Nootka & Sea, a privately held company operating in the apothecary and cosmetics space. PlantX…

Continue Reading

WednesdayMay 19, 2021 10:24 am

NetworkNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Announces On-Track Progress for Demonstration of i/Blue Imaging System(TM)

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging. Per the update, the company is on target to demonstrate the i/Blue Imaging System(TM) in private meetings during the American Urology Association (“AUA”) meeting to be held in early September. The product will showcase updates to meet performance criteria against competitive products and enhancements made to the design for manufacturing. “As the process moves forward, we’re creating the potential for additional IP that will…

Continue Reading

WednesdayMay 19, 2021 9:58 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Patient Enrollment in Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has begun open enrollment for its upcoming study focused on analyzing the efficacy and safety of Berubicin in the treatment of adult recurrent Glioblastoma Multiforme (“GBM”). GMB is one of the most aggressive types of brain cancer, and Berubicin, which is in development for the treatment of several serious brain and CNS oncology indications, is the first anthracycline to cross the blood-brain barrier. CNSP plans on enrolling some 210 subjects across 35 clinical sites…

Continue Reading

WednesdayMay 19, 2021 9:35 am

NetworkNewsBreaks – SRAX (NASDAQ: SRAX) Releases Q1 Revenue Growth, Increases Full-Year Guidance

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (”SaaS”) platform, posted a video on YouTube featuring founder and CEO Christopher Miglino along with CFO Michael Malone outlining the company’s operational and financial summary for Q1 2021. Highlights of the company’s financial report included the announcements that year-over-year revenue growth for the company was up 1,400%, with growth for Sequire alone up 2,800%; the company also increased its guidance for the year. Technology highlights from the report included the launch of the Sequire audience platform, where companies can host…

Continue Reading

WednesdayMay 19, 2021 9:30 am

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Resurgent Growth, Strong Q1 2021 Results

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide life sciences and other industries, today announced its best financial results in nearly three years for the first quarter ended March 31, 2021. Among the highlights, the company reported a 121% increase in total revenue for Q1 2021 to $559,900 compared to $253,900 for Q1 2020. “We had a remarkable first quarter. Sales increased across the board — in instruments, consumables and kits. Importantly, we saw a concomitant decline in operating loss,” said Richard T.…

Continue Reading